Interview
Pricing the Probability of Virus Risks
- U.S. equity markets are projected to sustain robust growth above trend through the end of the current year and most of the following year, contingent on successful state reopenings and a smooth transition following a brief pause.
- Under a baseline economic scenario, the S&P 500 is implied to reach a level of approximately 3,250.
- If a vaccine becomes available in the first quarter of 2021, annual economic growth is assumed to exceed 6%, driving the S&P 500 to approximately 3,520, which is about 10% above current levels.
- A downside scenario involving renewed restrictions or heightened caution is expected to stall economic growth and potentially result in modestly negative growth by the end of the year, causing equities to reprice to levels comparable to the March lows.
- Sector recovery trajectories differ, with manufacturing and construction anticipated to rebound relatively quickly, while services and face-to-face activities are expected to return slowly and steadily before accelerating upon vaccine availability.
- A full return to pre-pandemic "normal" is not expected by the end of 2021, though a significant shift in that direction is projected.
- Investor decision-making remains hindered by significant uncertainty regarding healthcare outcomes, their economic implications, and subsequent market effects.
- The equity market is anticipated to experience volatility over the next few weeks as it balances upside and downside probabilities, likely concluding near the levels observed in early June.
- Probability assessments for an early vaccine are increasing due to ongoing medical innovation news, while tentative data from late June suggests mitigation efforts in key states may be stabilizing the health situation.
- Short-term market direction will depend on data clarifying whether moderate restrictions, mask usage, and the removal of risky activities can control case growth without full lockdowns.